Cancer Research Donn Young  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauptschein, R. S.
Right arrow Articles by Jay, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauptschein, R. S.
Right arrow Articles by Jay, D. G.
[Cancer Research 65, 1887-1896, March 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Functional Proteomic Screen Identifies a Modulating Role for CD44 in Death Receptor–Mediated Apoptosis

Robert S. Hauptschein1, Kevin E. Sloan1, Claudia Torella2, Roya Moezzifard1, Maryann Giel-Moloney1, Carol Zehetmeier2, Christine Unger2, Leodevico L. Ilag2 and Daniel G. Jay1

1 Department of Physiology, Tufts University School of Medicine, Boston, Massachusetts and 2 Xerion Pharmaceuticals, AG, Munich, Germany

Requests for reprints: Daniel G. Jay, Department of Physiology, Tufts University School of Medicine, 7th Floor, M&V Building, 136 Harrison Avenue, Boston, MA 02111. Phone: 617-636-6714; Fax: 617-636-0445; E-mail: daniel.jay{at}tufts.edu.

Apoptotic evasion is a hallmark of cancer and its resistance to chemotherapeutic drugs. Identification of cellular proteins that mediate apoptotic programs is a critical step toward the development of therapeutics aimed at overcoming apoptosis resistance. We developed an innovative high-throughput screen to identify proteins that modulate Fas ligand–mediated apoptosis using fluorophore-assisted light inactivation (HTS-FALIpop). The FALI protein knockdown strategy was coupled to a caspase activity assay with the ability to detect both proapoptotic and antiapoptotic surface molecules expressed by HT-1080 human fibrosarcoma cells. FALI of the Fas receptor (Fas/CD95) using a fluorescein-conjugated anti-Fas antibody abrogated Fas ligand–mediated caspase activation. Ninety-six single-chain variable fragment antibodies (scFv), selected for binding to the surface of HT-1080 cells, were screened by HTS-FALIpop. Three of the scFvs caused decreases in caspase induction after FALI of their protein targets. One of the targets of these positive scFvs was identified as CD44 and was validated by performing FALI using a CD44-specific monoclonal antibody, which resulted in similar protection from Fas apoptosis. CD44-targeted FALI was antiapoptotic in multiple human cancer cell lines, including both Fas signaling type I and II cells, and was also protective against other ligands of the tumor necrosis factor death receptor family. FALI of CD44 inhibited formation and activation of the death-inducing signaling complex, suggesting that CD44 regulates Fas at the cell surface. This mechanism of death receptor regulation represents a novel means of apoptosis modulation that could be exploited by pharmacologic agents.

Key Words: functional proteomics • apoptosis • CD44 • fluorophore-assisted light inactivation • death receptor




This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
H. Hu, Y. Ran, Y. Zhang, Z. Zhou, S. J. Harris, L. Yu, L. Sun, J. Pan, J. Liu, J. Lou, et al.
Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target
Mol. Cell. Proteomics, April 1, 2009; 8(4): 816 - 826.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. Garcia-Crespo, E. Knock, N. Jabado, and R. Rozen
Intestinal Neoplasia Induced by Low Dietary Folate Is Associated with Altered Tumor Expression Profiles and Decreased Apoptosis in Mouse Normal Intestine
J. Nutr., March 1, 2009; 139(3): 488 - 494.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Zeilstra, S. P.J. Joosten, M. Dokter, E. Verwiel, M. Spaargaren, and S. T. Pals
Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis
Cancer Res., May 15, 2008; 68(10): 3655 - 3661.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Wang, S. Wang, H. Maeng, D. P. Young, O. Prakash, L. E. Fayad, A. Younes, and F. Samaniego
K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis
Blood, March 1, 2007; 109(5): 2174 - 2182.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Guo, H. Chen, H. L. Puhl III, and S. R. Ikeda
Fluorophore-assisted light inactivation produces both targeted and collateral effects on N-type calcium channel modulation in rat sympathetic neurons
J. Physiol., October 15, 2006; 576(2): 477 - 492.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Wang, Q.-Y. He, R. W.-Y. Sun, C.-M. Che, and J.-F. Chiu
Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species
Cancer Res., December 15, 2005; 65(24): 11553 - 11564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.